Newcastle disease virus: evaluation of an avirulent enteric isolate as a viable vaccine.
D000284:Administration, Oral; D000367:Age Factors; D000818:Animals; D000906:Antibodies / Q000032:analysis; D002645:Chickens; D005069:Evaluation Studies as Topic; D006385:Hemagglutination Inhibition Tests / Q000662:veterinary; D009521:Newcastle Disease / Q000150:complications / Q000517:prevention & control*; D009522:Newcastle disease virus / Q000276:immunology*; D011201:Poultry Diseases / Q000150:complications / Q000209:etiology / Q000517:prevention & control*; D012141:Respiratory Tract Infections / Q000209:etiology / Q000662:veterinary; D012703:Serotyping; D014765:Viral Vaccines / Q000592:standards*; D014774:Virulence
D000906:Antibodies; D014765:Viral Vaccines